Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and DurvalumabSilvia Camera, Giovanni Farinea, Mara Persano et al.|Targeted Oncology|2026Cited by 1
353P Prognostic role of metastatic sites in a worldwide population of patients with biliary tract cancer treated with cisplatin, gemcitabine, and durvalumabSilvia Camera, Lorenzo Fornaro, M. Rimini et al.|Annals of Oncology|2025Cited by 0